cilostazol has been researched along with Thrombopenia in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " At 7 and 30 days, the composite outcome for the group treated with cilostazol alone and that treated with abciximab in combination with cilostazol did not differ significantly." | 1.34 | Efficacy and safety of abciximab in combination with cilostazol in patients undergoing stenting. ( Hong, EH; Kim, MY; Lee, MH; Oh, JM; Park, JE; Shin, WG, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, EH | 1 |
| Kim, MY | 1 |
| Park, JE | 1 |
| Lee, MH | 1 |
| Oh, JM | 1 |
| Shin, WG | 1 |
1 other study available for cilostazol and Thrombopenia
| Article | Year |
|---|---|
Efficacy and safety of abciximab in combination with cilostazol in patients undergoing stenting.
Topics: Abciximab; Aged; Angina, Unstable; Antibodies, Monoclonal; Cilostazol; Coronary Angiography; Coronar | 2007 |